Sromek AW - Search Results

1

Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.

Lincoln L, Fisher R, Jackson MJ, Jenner P, Neumeyer J, Sromek AW, Lees AJ, Rose S. Lincoln L, et al. Among authors: sromek aw. Mov Disord. 2016 Sep;31(9):1381-8. doi: 10.1002/mds.26626. Epub 2016 May 2. Mov Disord. 2016. PMID: 27133947 Review.

2

Aminothiazolomorphinans with mixed κ and μ opioid activity.

Zhang T, Yan Z, Sromek A, Knapp BI, Scrimale T, Bidlack JM, Neumeyer JL. Zhang T, et al. J Med Chem. 2011 Mar 24;54(6):1903-13. doi: 10.1021/jm101542c. Epub 2011 Feb 25. J Med Chem. 2011. PMID: 21351746 Free PMC article.

3

Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.

Zhang B, Zhang T, Sromek AW, Scrimale T, Bidlack JM, Neumeyer JL. Zhang B, et al. Among authors: sromek aw. Bioorg Med Chem. 2011 May 1;19(9):2808-16. doi: 10.1016/j.bmc.2011.03.052. Epub 2011 Mar 26. Bioorg Med Chem. 2011. PMID: 21482470 Free PMC article.

4

Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors.

Sromek AW, Si YG, Zhang T, George SR, Seeman P, Neumeyer JL. Sromek AW, et al. ACS Med Chem Lett. 2011 Mar 10;2(3):189-194. doi: 10.1021/ml1001689. ACS Med Chem Lett. 2011. PMID: 21666830 Free PMC article.

5

Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.

Neumeyer JL, Zhang B, Zhang T, Sromek AW, Knapp BI, Cohen DJ, Bidlack JM. Neumeyer JL, et al. Among authors: sromek aw. J Med Chem. 2012 Apr 26;55(8):3878-90. doi: 10.1021/jm3001086. Epub 2012 Apr 4. J Med Chem. 2012. PMID: 22439881 Free PMC article.

6

Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors.

Provencher BA, Sromek AW, Li W, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL. Provencher BA, et al. Among authors: sromek aw. J Med Chem. 2013 Nov 14;56(21):8872-8. doi: 10.1021/jm401290y. Epub 2013 Oct 29. J Med Chem. 2013. PMID: 24107104 Free PMC article.

7

Preliminary pharmacological evaluation of enantiomeric morphinans.

Sromek AW, Provencher BA, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL. Sromek AW, et al. ACS Chem Neurosci. 2014 Feb 19;5(2):93-9. doi: 10.1021/cn400205z. Epub 2014 Jan 8. ACS Chem Neurosci. 2014. PMID: 24393077 Free PMC article.

8

(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.

Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C. Finnema SJ, et al. Among authors: sromek aw. J Nucl Med. 2014 Jul;55(7):1164-70. doi: 10.2967/jnumed.113.133876. Epub 2014 May 1. J Nucl Med. 2014. PMID: 24790219 Free PMC article.

9

Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine.

Sromek AW, Zhang S, Akurathi V, Packard AB, Li W, Alagille D, Morley TJ, Baldwin R, Tamagnan G, Neumeyer JL. Sromek AW, et al. J Labelled Comp Radiopharm. 2014 Dec;57(14):725-9. doi: 10.1002/jlcr.3246. Epub 2014 Nov 17. J Labelled Comp Radiopharm. 2014. PMID: 25400260 Free PMC article.

10

New Dopamine D2 Receptor Agonist, [³H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.

Subburaju S, Sromek AW, Seeman P, Neumeyer JL. Subburaju S, et al. Among authors: sromek aw. ACS Chem Neurosci. 2018 Jun 20;9(6):1283-1289. doi: 10.1021/acschemneuro.8b00096. Epub 2018 Apr 16. ACS Chem Neurosci. 2018. PMID: 29641175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page